Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (542)	12/12/2001 9:38:51 AM
From: tuck	Respond to of 1005

Parking this market info pertaining to former BLUE HP holding -- still on the WatchList -- CURN: >>MILWAUKEE, Dec. 12 /PRNewswire/ -- The December 11th edition of ``The New York Times'' reports that the incidence of GERD is on the rise. Millions of Americans think they have ordinary heartburn, when in reality they may have a more serious condition known as gastroesophageal reflux disease (GERD). Many people often mistake GERD as ordinary heartburn and suffer silently, blaming their symptoms on lifestyle or eating habits. If left untreated, GERD can lead to more serious conditions. Now IFFGD is encouraging those experiencing symptoms of GERD to call its toll free hotline at 1-888-964-2001 or visit the web site at aboutgerd.org to receive information and support about chronic heartburn or GERD. IFFGD urges Americans to see their doctor if they experience frequent or persistent heartburn more than twice a week and to call their toll free hotline for information and support. By seeking proper diagnosis and treatment, GERD patients can improve overall quality of life. FACTS: * More than 21 million Americans suffer from GERD, a chronic condition in which harsh stomach acid backs up into the esophagus or food tube. * About 40 percent of adults in the United States experience GERD at least once a month, according to a 1998 Gallup survey. * GERD costs an estimated $10.1 billion in the United States, including visits to the doctor, medications and time lost from work, according to the American Gastroenterology Association. Total costs for gastrointestinal diseases are in excess of $42 billion. * Less extreme cases of GERD were helped by a course of H2 blockers or proton pump inhibitors, according to a recent article in "The Journal of Family Practice." * A long-term study published this year in "The Journal of the American Medical Association" found that 129 men and women who either took proton pump inhibitors or had surgery reported roughly equal levels of satisfaction with their health and showed similar healing. Leading experts in the field of gastroenterology are available to speak with you about GERD as well as other gastrointestinal diseases. Please contact Michael Szumera or Theresa Liddy at 212-453-2000 for further information. SOURCE: The International Foundation for Functional Gastrointestinal Disorders<< Cheers, Tuck